Logo

American Heart Association

  21
  0


Final ID: MP1588

Risk Stratification with AI-Predictive Models vs. Traditional Clinical Risk Scores in Patients Undergoing Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis

Abstract Body (Do not enter title and authors here): Background
Atrial fibrillation (AF) recurrence after catheter ablation remains difficult to predict. While traditional risk scores such as CHA2DS2-VASc and HATCH are widely used, their predictive accuracy is modest. Machine learning (ML) models have emerged as a potential alternative, integrating multimodal data to enhance individualized risk stratification. We conducted a systematic review and meta-analysis to evaluate their predictive performance, model design, and comparison with clinical risk scores.
Methods
We searched PubMed, Embase, and Scopus for studies published between 2013 and 2024 using ML models to predict post-ablation AF recurrence. Eligible studies included adults undergoing catheter ablation and reported validation of ML model performance. Two reviewers independently extracted data on study design, sample size, input features, ML model type, validation method, AUROC, recurrence rates, and comparator clinical scores. Risk of bias was assessed using PROBAST.
Results
Eleven studies comprising 2,994 patients were included. Most were retrospective and conducted between 2013 and 2023 across China, the United States, Portugal, and Europe. Sample sizes ranged from 90 to 1,606, with follow-up durations from 6 months to 5.8 years. AF recurrence rates ranged from 21% to 54%. ML model types included gradient boosting (n=4), convolutional neural networks (n=3), logistic regression (n=2), regularized linear models (n=1), and simulation-based models (n=1). Input data varied from clinical variables (age, LA diameter, comorbidities) to ECG morphology, cardiac CT-based LA wall thickness, and electrogram-derived features. In three head-to-head comparisons, ML models outperformed traditional scores. For example, the HAD-AF model achieved an AUROC of 0.938 versus 0.679 for CHA2DS2-VASc. Average patient age ranged from 56 to 66 years, with >60% male across cohorts. The pooled sensitivity and specificity of ML models for predicting AF recurrence were 80.2% (95% CI: 77.7%–82.7%) and 76.5% (95% CI: 73.9%–79.2%), respectively. The pooled AUROC from five studies was 0.89 (95% CI: 0.86–0.92), reflecting strong discriminative ability across diverse populations and input modalities.
Conclusions
Machine learning models consistently outperformed traditional scores for predicting AF recurrence after ablation, with pooled AUROC nearing 0.90 and balanced sensitivity/specificity. Standardized external validation is essential for clinical implementation.
  • Mandava, Snigdha  ( NRI Medical College and Hospital , Nellore , Andhra Pradesh , India )
  • Shaik, Deekshith Ameer  ( Osmania medical college , Hyderabad , India )
  • Katikala, Venkata Ramana  ( onaseema Institute of Medical Sciences and Research Foundation , Amalapuram , India )
  • Bokka, Sri Lakshmi Ananya  ( Gandhi Medical College and Hospital , Secunderabad , India )
  • Sanghvi, Urja  ( C.U Shah Medical College, India , Ankleshwar , India )
  • Mohammed, Omer Farooq  ( Osmania Medical College , Hyderabad , India )
  • Panjiyar, Binay  ( North Shore University Hospital, Northwell Health , New York , New York , United States )
  • Nagoke, Simranjeet  ( Government Medical College Jammu , Jammu , India )
  • Afroze, Tanzina  ( TTUHSC, Amarillo , Amarillo , Texas , United States )
  • Madamanchi, Hari Krishna  ( Siddhartha Medical College , Nellore , India )
  • Korlakunta, Bhavana  ( Osmania Medical College , Aswapuram , India )
  • Author Disclosures:
    Snigdha Mandava: DO NOT have relevant financial relationships | deekshith ameer shaik: DO NOT have relevant financial relationships | Venkata Ramana Katikala: DO NOT have relevant financial relationships | Sri Lakshmi Ananya Bokka: DO NOT have relevant financial relationships | Urja Sanghvi: DO NOT have relevant financial relationships | Omer Farooq Mohammed: DO NOT have relevant financial relationships | Binay Panjiyar: No Answer | Simranjeet Nagoke: DO NOT have relevant financial relationships | Tanzina Afroze: DO NOT have relevant financial relationships | Hari Krishna Madamanchi: DO NOT have relevant financial relationships | Bhavana Korlakunta : DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Optimizing and Understanding Outcomes in Catheter Ablation and Complex Arrhythmia Management

Sunday, 11/09/2025 , 03:15PM - 04:15PM

Moderated Digital Poster Session

More abstracts on this topic:
A Multi-Tier, Natural-Language Processing Framework to Automate Labeling of Acute Cerebrovascular Events From Radiology Reports and Diagnosis Codes

Erekat Asala, Stein Laura, Delman Bradley, Karp Adam, Kupersmith Mark, Kummer Benjamin

A Machine Learning Readmission Risk Prediction Model for Cardiac Disease

Bailey Angela, Wang Wei, Shannon Clarence, Huling Jared, Tignanelli Christopher

More abstracts from these authors:
Impact of Cerebral Embolic Protection Devices on Stroke Outcomes in TAVR: A Systematic Review and Meta-Analysis of Randomized and Real-World Studies

Sanghvi Urja, Korlakunta Bhavana, Katikala Venkata Ramana, Mandava Snigdha, Bokka Sri Lakshmi Ananya, Wasir Amanpreet, Yonghang Sapana, Tandel Hemeesh, Mohammed Omer Farooq, Panjiyar Binay, Nagoke Simranjeet, Afroze Tanzina, Madamanchi Hari Krishna

Impact of Genetic Polymorphism on Antihypertensive Drug Response: Comparing ACE Inhibitors and ARBs – A Systematic Review and Meta-Analysis

Shaik Deekshith Ameer, Madamanchi Hari Krishna, Korlakunta Bhavana, Vemulaghat Krishna Teja, Gopu Sahithi, Katikala Venkata Ramana, Mandava Snigdha, Bokka Sri Lakshmi Ananya, Sanghvi Urja, Mohammed Omer Farooq, Panjiyar Binay, Nagoke Simranjeet, Afroze Tanzina

You have to be authorized to contact abstract author. Please, Login
Not Available